Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial

Title
Pomegranate juice to reduce fecal calprotectin levels in inflammatory bowel disease patients with a high risk of clinical relapse: Study protocol for a randomized controlled trial
Authors
Keywords
Ellagitannins, Pomegranate juice, <em class="EmphasisTypeItalic ">Punica granatum</em> L., Inflammation, Fecal calprotectin, IBD, Inflammatory bowel disease, Crohn’s disease, Ulcerative colitis
Journal
Trials
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-06
DOI
10.1186/s13063-019-3321-8

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation